Paul W. Scorer

Relevance of deep learning to facilitate the diagnosis of HER2 status in breast cancer

Michel E. Vandenberghe, Marietta Scott, Paul W. Scorer et al. · Scientific Reports · 2017 · 211 citations · Full text

Medicine, Oncology, Pathology +17

Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies

Nicola Lawson, Carly I. Dix, Paul W. Scorer et al. · Modern Pathology · 2019 · 87 citations · Full text

Medicine, Immunology, Oncology +17

Interobserver Reliability of Programmed Cell Death Ligand-1 Scoring Using the VENTANA PD-L1 (SP263) Assay in NSCLC

Gareth Williams, Andrew G. Nicholson, David Snead et al. · Journal of Thoracic Oncology · 2019 · 18 citations · Full text

Medicine, Oncology, Molecular Diagnostics +8

Impact of Decalcification, Cold Ischemia, and Deglycosylation on Performance of Programmed Cell Death Ligand-1 Antibodies With Different Binding Epitopes: Comparison of 7 Clones

Nicola Lawson, Paul W. Scorer, Gareth Williams et al. · Modern Pathology · 2023 · 15 citations · Full text

Pharmacy, Oncology, Pathology +17

Comparison of patient populations identified by different PD-L1 assays in head and neck squamous cell carcinoma (HNSCC)

Marietta Scott, Sophie Wildsmith, M. Ratcliffe et al. · Annals of Oncology · 2018 · 10 citations · Full text

Medicine, Oncology, Pathology +16